YD Bio and EG BioMed Partner with JoiiUp to Launch AI-Driven Cancer Risk Assessment for Corporate Wellness Programs

YD Bio and its affiliate EG BioMed have partnered with digital health provider JoiiUp to integrate an AI-driven cancer risk assessment tool into JoiiUp's JoiiSports app. The assessment, validated using over 1,200 clinical records from Taipei Medical University hospitals, analyzes demographic data and lifestyle factors across ten cancer types without requiring invasive testing. The tool will initially target corporate wellness programs through JoiiUp's network of 400+ companies, with planned expansion to healthcare institutions.